My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

252.74 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jul 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

5 Dividend Kings to Buy in July with Irristable Value and Yield ↗

July 08, 2026

Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.

Via MarketBeat

3 Reasons to Buy Novo Nordisk Stock ↗

July 07, 2026

The stock is down, but it isn't out yet.

Via The Motley Fool

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend ↗

July 07, 2026

Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.

Via The Motley Fool

Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation ↗

July 03, 2026

Via Chartmill

Topics Cannabis

Abivax: Wall Street Catches Up to the Data ↗

July 07, 2026

Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional...

Via MarketBeat

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) ↗

July 07, 2026

It doesn't get much more dependable and lucrative than the healthcare industry.

Via The Motley Fool

Topics Intellectual Property

The Dividend ETF Quietly Outperforming the S&P 500 ↗

July 07, 2026

This dividend ETF's focus beyond yield continues to pay off for investors.

Via The Motley Fool

Topics ETFs Stocks

Is Apple Stock a Buy After Its Recent Pullback? Here's What History Suggests. ↗

July 07, 2026

Look for history to repeat itself with Apple's latest pullback.

Via The Motley Fool

Topics Artificial Intelligence

3 Market-Beating Stocks Worth Investigating

July 07, 2026

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...

Via StockStory

Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway. ↗

July 06, 2026

Via Chartmill

Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

July 02, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its pe...

Via StockStory

Topics Artificial Intelligence

Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today ↗

July 01, 2026

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.03% on an annualized basis producing an average annual return of 16.59%. Currently, AbbVie has a market capitalization of...

Via Benzinga

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Via GlobeNewswire

This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy? ↗

June 30, 2026

AbbVie knows how to plan ahead.

Via The Motley Fool

Topics Intellectual Property

3 No-Brainer Dividend Stocks to Buy Right Now ↗

June 29, 2026

AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.

Via The Motley Fool

Topics Intellectual Property

AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy? ↗

June 29, 2026

In the past five years, this top healthcare stock has risen by close to 130%.

Via The Motley Fool

2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky

June 29, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Retirement Stocks

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? ↗

June 25, 2026

AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.

Via The Motley Fool

Topics Intellectual Property

Is AbbVie a Buy After Its Purchase of Apogee? ↗

June 25, 2026

The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?

Via The Motley Fool

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

June 25, 2026

From Biotech Insider

Via GlobeNewswire

Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years ↗

June 24, 2026

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 4.21% on an annualized basis producing an average annual return of 15.79%. Currently, AbbVie has a market capitalization of...

Via Benzinga

2 Value Stocks Worth Your Attention and 1 Facing Headwinds

June 24, 2026

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...

Via StockStory

3 Monster Stocks to Hold for the Next 10 Years ↗

June 23, 2026

These healthcare stocks may be the building blocks of a winning portfolio.

Via The Motley Fool

Topics Intellectual Property

Why AbbVie Stock Jumped Today ↗

June 22, 2026

An intriguing acquisition could bring exciting new drugs into the medicine maker's development pipeline.

Via The Motley Fool

AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? ↗

June 22, 2026

The company is already renowned by many as a giant in the segment.

Via The Motley Fool

Monday's session: top gainers and losers in the S&P500 index ↗

June 22, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Explore the top gainers and losers within the S&P500 index in today's session. ↗

June 22, 2026

Via Chartmill

5 Dividend Stocks to Buy and Hold Forever ↗

June 22, 2026

Get rich slowly. How? Hold these stocks and reinvest the dividends they pay.

Via The Motley Fool

Topics Intellectual Property

3 Excellent Dividend Stocks to Buy on the Dip ↗

June 22, 2026

Don't wait too long to get in on these outstanding dividend payers.

Via The Motley Fool

Topics Artificial Intelligence Economy Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.